SARS-CoV-2 infection tagged posts

Scientists deliver siRNA Therapy to Lung

Fluoresce images of lung tissue after treatment (top, red), show local distribution of chemically modified siRNA and robust gene silencing in the lung.

Delivery technology successfully blocks SARS-CoV-2 infection in mice; adaptable for multiple diseases

Scientists at UMass Chan Medical School have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease.

Published in the journal Proceedings of the National Academy of Sciences, the study by a multidisciplinary team of RNA biologists, chemical biologists, immunologists and virologists describes the delivery of siRNA molecules locally to lung tissue...

Read More

COVID-19 Can Trigger Self-Attacking Antibodies

Photo by Getty Images.
An illustration of antibodies (Y-shaped) responding to SARS-CoV-2 (orange), the novel coronavirus that causes COVID-19.

Infection with the virus that causes COVID-19 can trigger an immune response that lasts well beyond the initial infection and recovery—even among people who had mild symptoms or no symptoms at all, according to Cedars-Sinai investigators. The findings are published in the Journal of Translational Medicine.

When people are infected with a virus or other pathogen, their bodies unleash proteins called antibodies that detect foreign substances and keep them from invading cells. In some cases, however, people produce autoantibodies that can attack the body’s own organs and tissues over time.

The Cedars-Sinai investigators found that people w...

Read More